These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 7831387)
21. Evaluation of BTS 67 582, a novel antidiabetic agent, in normal and diabetic rats. Jones RB; Dickinson K; Anthony DM; Marita AR; Kaul CL; Buckett WR Br J Pharmacol; 1997 Mar; 120(6):1135-43. PubMed ID: 9134227 [TBL] [Abstract][Full Text] [Related]
22. Possible involvement of ATP-sensitive K+ channels in the relaxant response of dog middle cerebral artery to cromakalim. Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M J Pharmacol Exp Ther; 1990 Nov; 255(2):818-25. PubMed ID: 2123008 [TBL] [Abstract][Full Text] [Related]
23. (-)-(9S)-9-(3-Bromo-4-fluorophenyl)-2,3,5,6,7,9-hexahydrothieno[3,2-b]quinolin-8(4H)-one 1,1-dioxide (A-278637): a novel ATP-sensitive potassium channel opener efficacious in suppressing urinary bladder contractions. I. In vitro characterization. Gopalakrishnan M; Buckner SA; Whiteaker KL; Shieh CC; Molinari EJ; Milicic I; Daza AV; Davis-Taber R; Scott VE; Sellers D; Chess-Williams R; Chapple CR; Liu Y; Liu D; Brioni JD; Sullivan JP; Williams M; Carroll WA; Coghlan MJ J Pharmacol Exp Ther; 2002 Oct; 303(1):379-86. PubMed ID: 12235274 [TBL] [Abstract][Full Text] [Related]
24. Comparison of effects of cromakalim and pinacidil on mechanical activity and 86Rb efflux in dog coronary arteries. Masuzawa K; Asano M; Matsuda T; Imaizumi Y; Watanabe M J Pharmacol Exp Ther; 1990 May; 253(2):586-93. PubMed ID: 2160002 [TBL] [Abstract][Full Text] [Related]
26. Potassium channel opening properties of thiazide diuretics in isolated guinea pig resistance arteries. Calder JA; Schachter M; Sever PS J Cardiovasc Pharmacol; 1994 Jul; 24(1):158-64. PubMed ID: 7521481 [TBL] [Abstract][Full Text] [Related]
27. K+ channel activators, acute glucose tolerance and glibenclamide-induced hypoglycaemia in the hypertensive rat. Clapham JC; Trail BK; Hamilton TC Eur J Pharmacol; 1994 May; 257(1-2):79-85. PubMed ID: 8082711 [TBL] [Abstract][Full Text] [Related]
28. RP 49356 and cromakalim relax airway smooth muscle in vitro by opening a sulphonylurea-sensitive K+ channel: a comparison with nifedipine. Raeburn D; Brown TJ J Pharmacol Exp Ther; 1991 Feb; 256(2):480-5. PubMed ID: 1899701 [TBL] [Abstract][Full Text] [Related]
29. Relaxation by cromakalim and pinacidil of isolated smooth muscle cells from canine coronary artery-multiple sites of action. Rhim BY; Hong KW Arch Int Pharmacodyn Ther; 1994; 328(1):67-81. PubMed ID: 7893192 [TBL] [Abstract][Full Text] [Related]
30. Alterations by glyburide of effects of BRL 34915 and P 1060 on contraction, 86Rb efflux and the maxi-K+ channel in rat portal vein. Hu SL; Kim HS; Okolie P; Weiss GB J Pharmacol Exp Ther; 1990 May; 253(2):771-7. PubMed ID: 2110977 [TBL] [Abstract][Full Text] [Related]
31. ICI 206,970: a novel calcium channel blocker with eukalemic diuretic activity. Howe BB; Keith RA; Do ML; Halterman TJ; Donahue JY; Schwartz JA; Kau ST Pharmacology; 1993 Dec; 47(6):369-77. PubMed ID: 8278459 [TBL] [Abstract][Full Text] [Related]
32. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. Cavero I; Mondot S; Mestre M J Pharmacol Exp Ther; 1989 Mar; 248(3):1261-8. PubMed ID: 2495353 [TBL] [Abstract][Full Text] [Related]
33. Hypoglycemic sulfonylureas antagonize the effects of cromakalim and pinacidil on 86Rb fluxes and contractile activity in the rat aorta. Lebrun P; Fang ZY; Antoine MH; Herchuelz A; Hermann M; Berkenboom G; Fontaine J Pharmacology; 1990; 41(1):36-48. PubMed ID: 2122482 [TBL] [Abstract][Full Text] [Related]
34. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta. Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826 [TBL] [Abstract][Full Text] [Related]
35. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta. Lodge NJ; Halaka NN J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016 [TBL] [Abstract][Full Text] [Related]
36. Effects of potassium channel blockers on the negative inotropic responses induced by cromakalim and pinacidil in guinea pig atrium. Lau WM Pharmacology; 1992; 45(1):9-16. PubMed ID: 1508969 [TBL] [Abstract][Full Text] [Related]
37. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue. Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325 [TBL] [Abstract][Full Text] [Related]
38. Potassium channel-opening and vasorelaxant profiles of a novel compound YM099 in rat isolated portal vein and rabbit isolated aorta. Uchida W; Hirano Y; Shirai Y; Taguchi T; Masuda N; Shibasaki K; Hirano S; Matsumoto Y; Tsuzuki R; Yanagisawa I Arch Int Pharmacodyn Ther; 1994; 327(3):330-43. PubMed ID: 7848015 [TBL] [Abstract][Full Text] [Related]
39. Effect of glibenclamide on membrane response to metabolic inhibition in smooth muscle of rat portal vein. Lydrup ML; Swärd K; Hellstrand P J Vasc Res; 1994; 31(2):82-91. PubMed ID: 8117863 [TBL] [Abstract][Full Text] [Related]
40. Antihypertensive and haemodynamic properties of the potassium channel activating (-) enantiomer of cromakalim in animal models. Clapham JC; Hamilton TC; Longman SD; Buckingham RE; Campbell CA; Ilsley GL; Gout B Arzneimittelforschung; 1991 Apr; 41(4):385-91. PubMed ID: 1907150 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]